Vismodegib CAS % 7b{0}}}

Mahsulot tavsifi:

Mahsulot nomi:Vismodegib CAS 879085-55-9

 

Sinonimlar:

2-Xloro-N-[4-xlor-3-(2-piridinil)fenil]-4-(metilsulfonil)benzamid;BROMO-1-NAPHTA

BenzaMide, 2-xloro-N-[4-xloro-3-(2-piridinil)fenil]-4-(Metilsulfonil)-;

VisModegib (GDC-0449)% 3b

 

Kimyoviy va jismoniy xususiyatlari

Tashqi ko'rinishi: Oqdan to'liq oqgacha

Tahlil: 99%+

Qaynash nuqtasi: 561,6±50,0 daraja

Erish nuqtasi:179-181 daraja

Molekulyar og'irligi: 421,3

Zichlik: 1,440

Pka:10.72±0.70

Barqarorlik: Sotib olingan kundan boshlab 2 yil davomida barqaror. DMSO yoki etanoldagi eritmalar -20 darajada 3 oygacha saqlanishi mumkin.

 

Ilova:

Vimodej targets SMO protein and inhibits Gli activation, thereby inhibiting downstream gene transcription and expression.For the treatment of locally progressive or metastatic basal cell carcinoma in adults who have recurred after surgery or are not well treated with surgery or radiotherapy; One of the most common skin cancers is basal cell carcinoma (BCC), which originates in the surface layer of the skin and does not cause pain to patients. The risk was greatest for skin diseases that were regularly exposed to the sun or ultraviolet light. The development and listing of Vimedji has brought good news to patients with BCC, and its clinical role is important and the target market is huge, and it has to grow into a "giant bomb" class (>1 milliard dollar) kelajakda dori.

 

 

 

Mahsulotlarimiz bilan qiziqsangiz yoki savollaringiz bo'lsa, biz bilan bog'laning!

 

 

Patent ostidagi mahsulotlar faqat Ar-ge maqsadida taklif etiladi. Biroq, yakuniy javobgarlik faqat xaridorga tegishli.

Issiq teglar: vismodegib cas 879085-55-9, ishlab chiqaruvchilar, yetkazib beruvchilar, zavod, sotib olish, stokda

• Oldingi: Tricine CAS % 7b{0}}}
• Keyingi2: Trametinib CAS 871700-17-3